EGFR and urinary bladder cancer: A considerable proportion of patients exhibited positive expression for p53 (69.0%), Ki-67 (62.1%), EGFR (55.2%), and CK20 (75.9%), indicating the frequent dysregulation of these biomarkers in bladder cancer.